Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 27, 2026
Una segunda oportunidad para los linfocitos T-CAR en el osteosarcoma
Del laboratorio de Meshinchi, Departamento de Investigación Clínica y Departamento de Ciencias Traslacionales y Terapéutica
Giving CAR T a second life in osteosarcoma
From the Meshinchi Lab, Clinical Research Division and Translational Science and Therapeutics Division
Age-dependent genetic alterations in AML patients
From the Meshinchi Lab, Translational Science & Therapeutics Division
Flipping out to develop an intracellular protein-targeting CAR T cell therapy to treat AML
From the Meshinchi Lab, Clinical Research and Translational Science and Therapeutics Divisions.
Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies
From the Meshinchi Lab, Clinical Research Division
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues